This report discusses the evidence supporting the effectiveness of screening, brief intervention, and referral to treatment (SBIRT) as a comprehensive approach, as well as for the implementation and effectiveness of the individual components of SBIRT for different behavioral health conditions.

This community-based tool consists of a two-day workshop that brings together stakeholders in the criminal justice, behavioral health, and recovery support systems to identify strengths, gaps, and priorities in their communities, and can strengthen the community response to the opioid crisis. 

Sequential Intercept Mapping (SIM) identifies the vital places in the system where best practices should be implemented, thereby increasing a person’s chances of recovery and decreasing recidivism. 

Shatterproof is a national nonprofit organization dedicated to reversing the addiction crisis in the United States, with an emphasis on reducing stigma and access to quality treatment. 

This is a report which outlines the extent and impact that addiction discrimination and stigma have on individuals with substance use disorder. The report includes data collected by the Shatterproof Addiction Stigma Index, a measurement tool designed to specifically measure addiction stigma and attitudes of the public on substance use. 

This is a coronavirus toolkit from Shatterproof for addiction treatment providers. There are links to finding specific information on telehealth/telemedicine, state policies on opioid treatment providers (OTPs) operation during the pandemic, and insurance guidance. 

This is a report from Shatterproof that shows the supply of healthcare professionals (HCP) waivered to prescribe buprenorphine on the the state and county level. Nationally, less than 6% of HCP are waivered to prescribe buprenorphine and a little more than 3% have publicly disclosed they they are prescribers. 

This is an academic paper that examines the social roots of the opioid crisis, creating a social determinants of health framework to better understand opioid-related harms across the drug-use continuum. Findings suggest that policymakers and public health leaders should develop partnerships with people who use drugs, incorporate harm reduction strategies, and reverse drug criminalization policies. 

This is a statistical brief from the Healthcare Cost and Utilization Project (HCUP) that describes how counties that have high versus low population rates of opioid-related hospital use differ with regard to social determinants of health (SDOH). The SDOH studied include social, educational, and economic characteristics; physical infrastructure; and healthcare characteristics. Results show that counties with high population rates of opioid-related hospital use have a meaningfully different SDOH profile. 

This is a report that describes how State Offices of Rural Health (SORH) are aiding their rural communities in responding to the addiction crisis, while meeting the expectations of SORH grants. Initiatives across the nation are highlighted, with a focus on collection and dissemination of information, coordination of rural health activities, and technical assistance. 

This toolkit from the American Society of Addiction Medicine (ASAM) provides a framework for organizing addiction treatment systems and a foundation for improving the quality of care for substance use disorder (SUD) treatment. The toolkit outlines the ASAM criteria, which offers evidence based guidelines for patient placement, continued stay, and transfer of patients with addictive, substance related and co occurring conditions. Its goal is to aid states in integrating the ASAM criteria into SUD treatment. 

This toolkit introduces the ASAM criteria, a framework for organizing addiction treatment systems and a foundation for improving the quality of care and addressing the gap between the efficacy of treatment in clinical trials and effectiveness in real world settings. By rooting substance use disorder (SUD) services in a common framework such as the ASAM criteria, states can ensure that organizations are "speaking the same language" when it comes to SUD prevention and treatment.  

This report published by the National Academy for State Health Policy (NASHP) gives an overview on the connection between opioid use disorder and neonatal abstinence syndrome (NAS). The report also highlights state approaches to NAS data collection, analysis, and cross-agency data linkage, and how states leverage these data to inform better policy and improve health outcomes for both parents and infants.